You are here

Article Text

Article menu
Download PDFPDF
ePoster
EP1270 Risk of ovarian cancer in women with histological proven endometriosis. The ENOCA a population-based cohort study
  1. M Hermens1,2,
  2. A van Altena2,
  3. B Nieboer2,
  4. D Schoot1,3,
  5. H van Vliet1,
  6. B Siebers4,5 and
  7. R Bekkers1,6
  1. 1Obstetrics and Gynaecology, Catharina Hospital, Eindhoven
  2. 2Obstetrics and Gynaecology, Radboudumc, Nijmegen, The Netherlands
  3. 3Obstetrics and Gynaecology, University Hospital Ghent, Ghent, Belgium
  4. 4Pathology, Radboudumc, Nijmegen
  5. 5PALGA, the Nationwide Network and Registry of Histo- and Cytopathology in the Netherlands, Houten
  6. 6GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands

Abstract

Introduction/Background Several studies have suggested that endometriosis is associated with an increased risk of ovarian cancer. However they lack sufficient power, follow-up data, or diagnostic certainty. We used a large nationwide pathology database to assess whether there is an association between endometriosis and ovarian cancer.

Methodology We identified all women with a histological diagnosis of endometriosis between 1990 and 2015 from the Dutch nationwide registry of histopathology and cytopathology (PALGA), and matched with women with a benign dermal nevus. Histology results for cancer of the ovaries, fallopian tubes, and peritoneum between January 1990 and July 2017 were retrieved. Incidence rate ratios (IRR) were estimated for ovarian cancer.

Results The crude IRR for ovarian cancer in endometriosis patients was 4.80 (95%CI 4.34 to 5.32), and the age-adjusted IRR was 7.22 (95%CI 6.20 to 8.41) (table 1). Median age at ovarian cancer diagnosis was significantly different, 56 years (IQR 49 to 63) and 60 years (IQR 53 to 67) in the endometriosis and nevus group respectively. After excluding cases with less than a half-year of follow-up, the age-adjusted IRR was 1.09 (95%CI 0.88 to 1.35). In both analyses endometrioid and clear cell cancers were significantly more associated with endometriosis (figure 1).

Conclusion These findings show a five to seven times higher prevalence of ovarian cancer in endometriosis patients. To our knowledge, this is the largest study to investigate the risk of ovarian cancer in women with endometriosis and the first study to only include patients with histological proven endometriose. Women with endometriosis are on average four years younger at ovarian cancer diagnosis. We found a large proportion of women with synchronous endometriosis and ovarian cancer after the average menopausal age, this suggests that the risk of cancer remains, even when clinical symptoms of endometriosis are no longer present.

Disclosure Nothing to disclose

View this table:
Abstract EP1270 Table 1

Incidence rate per 100,000 person-years, crude incidence rate ratios and age-adjusted incidence rate ratios of ovarian cancer

Abstract EP1270 Figure 1
Abstract EP1270 Figure 1

Ovarian cancer distribution per histological subtype in the endometriosis group and nevus group

https://doi.org/10.1136/ijgc-2019-ESGO.1276

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.